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The aggregation and fibrillation of α-synuclein has been implicated as a causative factor in the Parkinson’s 
disease. The hexamer motif KTKEGV is found in each of the seven imperfect repeat sequences in the N-terminal 
half of α-synuclein. The motif is not fully conserved in the sixth and seventh repeats. We created mutants in 
which the motif was repaired to be fully conserved in either (Rep6 and Rep7) or both (Rep67) of these two 
repeats. The Rep6 and Rep67 mutants showed a greatly reduced propensity to aggregate and fibrillate while all 
three mutants showed greater resistance to HFIP-induced formation of the α-helix intermediate. Resistance to 
formation in the partially folded intermediate may repress the folding of α-synuclein, consequently interfering 
with the aggregation and fibril formation. These results demonstrated that KTKEGV repeats may have a 
significant role in keeping native unfolded status of α-synuclein. 
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1.  Introduction 
Several neurodegenerative disorders have been 
characterized by the deposition and accumulation of 
abnormal protein components in cells, leading to 
selective synaptic damage. Such disorders are often 
described according to the type of misfolded and 
deposited protein, although it is not fully understood 
what causes the abnormal protein folding and 
accumulation as well as how they become cytotoxic. 
Alzheimer’s disease (AD) and Lewy body (LB) disease, 
represented by Parkinson’s disease (PD), are the most 
common neurodegenerative diseases, which are 
characterized by the accumulation of the misfolded 
proteins  β-amyloid and α-synuclein, respectively. 
That  α-synuclein is the major fibrillar protein 
component of LB in both sporadic and familial PD, 
and that two different α-synuclein missense 
mutations (A53T [1, 2] and A30P [3]) cause 
autosomal-dominant PD, strongly support a causative 
role for α-synuclein in PD pathogenesis. 
α-Synuclein is a relatively abundant brain 
protein of unknown function that is a type of natively 
unfolded proteins (disordered proteins) [4], which 
have little or no ordered structure under physiological 
conditions  in vitro. The protein’s 140-amino acid 
amino acid sequence consists of an N-terminal region 
(residues 1-95) containing seven 11-residue repeats 
(XKTKEGVXXXX) that include a highly conserved 
KTKEGV hexameric motif, and an acidic C-terminal 
region (residues 96-140). Similarities in these 
11-residue repeats with those found in 
apolipoproteins have suggested a possible role in the 
association of α-synuclein with lipid through 
formation of α-helical secondary structure [5, 6]. 
Furthermore, portions of the α-synuclein N-terminal 
region have been reported to adopt an α-helical 
structure and bind SDS micelles [7-9] and lipid 
vesicles [10]. α-Synucleins binding to lipid vesicles 
have been reported not to fibrillate in vitro [11]. These 
repeat sequences also have an effect of decreasing the 
tendency of α-synuclein to form β-sheet structures, 
such as fibrils [12]. The central region of α-synuclein 
(residues 61-95), known as the non-amyloid β 
component of Alzheimer’s disease amyloid (NAC), is 
recognized as the core region responsible for the 
formation of fibrils [13], which have a β-sheet-rich 
structure [14]. 
However, none has ever reported on the role of 
KTKEGV repeated sequence in α-synuclein structure, 
particularly in the protein folded process and/or 
keeping its random structure. The lack in the 
information about the role of this one of the 
characteristic primary sequence in α-synuclein, 
KTKEGV, inspired us to initiate the reparation of 
imperfect sequence in this molecule. Interestingly, 
among the seven 11-amino acid imperfect repeats, the 
characteristic hexameric motifs in the two repeats 
located within the NAC region are not conserved 
(Figure 1). In order to investigate the role of these two 
non-conserved hexameric motifs on the aggregation 
and fibril formation ability of α-synuclein, we carried 
out a site-directed mutagenesis study on this region. 
We constructed three mutant α-synucleins in which 
either or both of the nonconserved hexameric motifs 
in the 6th and 7th repeats were substituted to the 
conserved KTKEGV sequence (Figure 1). We 
investigated the propensity of the mutant 
α-synucleins to form fibrils and aggregates, as well as 
their propensity to form α-helices. Our findings 
suggest that the two 11-residue repeat sequences in 
the NAC region have a strong effect on α-synuclein 
folding and the 6th repeat sequence has a particularly Int. J. Biol. Sci. 2007, 3  2
strong influence on α-synuclein’s propensity to  aggregate  and  fibrillate. 
Fig. 1. α-Synuclein mutants introduced amino acid substitution into the incomplete repeat sequences in NAC region. 
The boxed regions indicate incomplete repeat regions. Red letters indicate conserved amino acids in the characteristic 
hexamer motif (KTKEGV). Green letters represent the mutated residues. 
 
2.  Materials and Methods 
Chemicals 
Thioflavin T (TfT) was obtained from Sigma. 
1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) was 
obtained from Wako. 
Recombinant technology 
PCR amplification of the α-synuclein structural 
gene was carried out using a human bone marrow 
cDNA library as the template and the following 
oligonucleotide primer pair: 
5’-CCAAGCTTCATATGGATGTATTCATGAAAGG
ACTTTCAAAGG-3’ (forward) and 
5’-GGTACCCTTGGCAAAGCAGGCTTCAGGTTCG
TAGTCTTGATA-3’ (reverse). The forward primer 
was designed with an NdeI immediately following a 
HindIII site, while the reverse primer has a KpnI site at 
its 5’ end (all sites are underlined). Amplification was 
carried out using Ampli-Taq Gold DNA polymerase 
(Roche) with 35 cycles of 95 oC for 1 min, 55 oC for 1 
min, and 72 oC for 1 min. The amplified fragment was 
cloned into the pGEM-T TA cloning vector (Promega) 
and its sequence was confirmed by automated DNA 
sequencing (Perkin Elmer ABI Model 310). 
The HindIII-KpnI fragment of the pGEM-T clone, 
containing the amplified α-synuclein gene, was 
i n s e r t e d  i n t o  t h e  v e c t o r  p K F 1 9 k  t o  c a r r y  o u t  
site-directed mutagenesis using Mutan®-Super 
Express Km (Takara, Japan). Mutations were 
introduced with the following oligonucleotides: 
5’-GTGACAAATGTTGGAGGAAAAACAAAAGAA
GGTGTGACAGCAGTAGCC-3’ (Rep6 
(Ala69Lys/Val70Thr/Val71Lys/Thr72Glu)), 
5’-CCCAGAAGACAAAAGAGGGAGCAGG-3’ 
(Rep7 (Val82Lys)). The mutant Rep67 
(Ala69Lys/Val70Thr/Val71Lys/Thr72Glu/Val82Lys) 
was created using the two primers for Rep6 and Rep7 
simultaneously. After confirming the mutations by 
DNA sequencing, the wild type and mutated genes 
were digested with NdeI and KpnI and inserted into 
pTYB1 (New England Biolabs) expression vectors. 
Wild type and mutant α-synuclein genes in 
pTYB1 were expressed in E. coli with C-terminal 
intein/chitin binding domain tags and purified using 
the IMPACT T7 one-step protein purification system 
(New England Biolabs). This system allowed simple 
purification of α-synucleins by binding of the fusion 
proteins to a chitin column, followed by addition of a 
thiol agent (dithiothreitol) to induce the self-cleavage 
reaction of the intein and release the α-synucleins. The 
resultant proteins were highly homogeneous by 
SDS-PAGE and their concentrations were determined 
by the DC protein assay kit (BioRad). 
Circular dichroism measurements  
CD spectra of 0.2 mg/ml α-synucleins at 25 oC 
were recorded from 190 to 250 nm in a 0.1 cm cell, a 
1.0 nm bandwidth, a 4 s response time, and a scan 
speed of 20 nm/min using a J-720 spectropolarimeter 
(JASCO). Each spectrum was generated from the 
average of five scans. The CD spectrum of 10 mM Tris 
buffer, pH 7.4, was used as background and 
subtracted from the protein spectra. The data were 
presented as the mean residue molar ellipticity 
(deg·cm2·dmol-1). 
Fibril formation analysis 
All protein samples were concentrated to approx. 
10 mg/ml by using Amicon Ultra-15 filters (Millipore) 
in 10 mM Tris-HCl, pH 7.4, and were centrifuged at 
150,000g for 60 min to remove insoluble aggregates. 
α-Synucleins were incubated at concentrations of 2.0 
mg/ml in 0.5 ml of the same buffer with 0.02% NaN3 
at 37 oC with shaking in 1.5 ml tubes. Fibril formation 
was monitored by Thioflavin T (TfT) fluorescence by 
transferring 10 μl aliquots from the incubated sample 
to 1.0 ml of 25 μM TfT in 10 mM Tris buffer, pH 7.4. 
Fluorescence measurements were performed in a 
FP6500 spectrofluorometer (JASCO) with a 0.5 cm 
excitation light path. TfT fluorescence was recorded 
immediately after addition of protein aliquots to the 
TfT mixture at 1 nm increments from 460 to 560 nm, 
with an excitation of 450 nm, response time of 1 s, scan 
speed of 100 nm/min, and slits of 5 nm for both 
excitation and emission. For each sample, a blank 
measurement recorded prior to addition of 
α-synuclein to the TfT solution was subtracted from 
the final TfT intensity at 482 nm. All data were Int. J. Biol. Sci. 2007, 3  3
processed using Spectra Manager (JASCO) software. 
Rayleigh light scattering at 330 nm was used to 
monitor the total aggregation. 
1,1,1,3,3,3-Hexafluoro-2-propanol titration 
HFIP was added to a 0.6 mg/ml α-synuclein 
solution in 10 mM Tris-HCl, pH 7.4, and diluted with 
the same buffer to obtain final concentrations of 0 to 
10% (v/v) HFIP and 0.2 mg/ml α-synuclein. Samples 
were analyzed by CD spectroscopy after incubation at 
room temperature for 24 hours. 
3.  Results and Discussion 
Aggregation and fibrillation of wild type and 
mutant α-synuclein. 
The far-UV CD spectrum of the prepared 
wild-type human recombinant α-synuclein sample is 
almost indistinguishable from those of the Rep6, Rep7, 
and Rep67 α-synuclein mutants (Figure 2). The CD 
spectra of these samples are typical of an essentially 
unfolded polypeptide chain, including the 
characteristic minima in the vicinity of 198 nm. These 
results show that the amino acid substitutions had no 
impact on the native state of α-synuclein. 
Fig. 2. Secondary structures of α-synuclein and its mutants. CD spectra of α-synucleins determined after purification: 
WT (black), Rep6 (blue), Rep7 (red), Rep67 (green).  
 
Fig. 3. Effect of amino acid substitution on amyloid fibril formation of α-synuclein. Time course of fibril formation of 
α-synuclein and its mutants as determined by TfT fluorescence assay analysis: WT (black circles), Rep6 (blue triangles), 
Rep7 (red squares), Rep67 (green diamonds). 
 
 
 
The prepared wild type and mutant α-synuclein 
samples were investigated for their aggregation and 
fibril formation abilities using the fluorescent dye TfT. 
Because TfT appears to embed itself within the 
clearance of pleats of  β-sheets, it interacts quite Int. J. Biol. Sci. 2007, 3  4
specifically with fibrils but not with most native 
proteins or amorphous aggregates. Binding of TfT to 
protein fibrils is accompanied by a characteristic 
increase in the fluorescence intensity in the vicinity of 
482 nm [15]. Comparison of the fibrillation patterns of 
wild type and mutant α-synucleins (Figure 3) shows 
that Rep7 has a similar fibrillation rate and higher 
maximal fluorescence intensity than wild type. 
Therefore, reparation of the 7th repeat sequence, 
mutating it to contain the characteristic KTKEGV 
hexameric motif, did not affect the propensity of fibril 
formation. In contrast, Rep6 and Rep67 had much 
lower fibril formation rates than both wild type and 
Rep7, with maximal fibril formation values less than 
10% of the wild-type value. Therefore, both Rep6 and 
Rep67 achieved great reductions in fibril formation 
ability by reparation of the 6th repeat sequence to 
contain the characteristic hexamer motif. 
Light scattering from protein solutions is 
recognized as an association-dependent parameter 
reflecting the formation of large particles. Unlike TfT, 
the increase in static light scattering reflects the 
formation of all large particles, both fibrillar and 
amorphous, including large soluble oligomers. Total 
α-synuclein aggregation levels were determined by 
light scattering and compared (Figure 4). While the 
aggregation of Rep7 after 120 hours of incubation was 
almost identical to that of wild type, Rep6 and Rep67 
were much less prone to aggregate. These results 
suggest that reparation of the 6th conserved 
characteristic hexamer motif has an especially strong 
effect on α-synuclein aggregation and fibrillation. 
Fig. 4. Changes in α-synuclein light-scattering. The 
OD330 values recorded after incubation of the samples were 
subtracted from those before incubation to determine their 
decrease in light-scattering (ΔOD330).  
 
 
The primary structure at the NAC region 
strongly characterizes the preference of the formation 
of fibril. As we and other researcher reported [16, 17], 
the amino acid substitution at NAC region may result 
in the formation of less amyloid forming prone 
mutant  α-synuclein, only if the introduced residues 
are positive toward the resistance in fibril formation. 
However, simultaneous substitution of 4 residues 
without changing their random and water soluble 
s t r u c t u r e s ,  i s  h a r d  t o  b e  a c h i e v e d .  T o  d e s i g n  s u c h  
simultaneous multi residues substitution, the precise 
prediction of possible secondary structure at the target 
region and the information about the interaction of 
residues under the folded condition are necessary, 
although few structural information in the folded 
structure of α-synuclein is available. Our results 
indicated that the introduction of KTKEGV sequence 
at the NAC region resulted in drastic decrease in the 
fibril formation ability without losing its primary 
random structure and its water solubility. This fact 
indicated that KTKEGV is a sequence which may have 
a crucial role in preventing amyloid fibril formation, 
keeping its random structure in a water soluble form. 
Considering that the replacement of NAC region itself 
may result in negative effect of amyloid forming 
ability, Rep6 showed less prone in amyloid forming 
than Rep7. 
α-Helix formation by wild type and mutant 
α-synucleins in the presence of HFIP. 
HFIP was used to induce the conversion of 
α-synucleins to an α-helical structure, which was 
monitored by far-UV CD spectra. Solutions containing 
the wild type protein (data not shown) and Rep6 
(Figure 5) showed increased secondary structure with 
increasing HFIP. The minima at 198 nm, representing 
random structure, were converted to peaks with large 
positive ellipticity. This was accompanied by the 
appearance of minima around 208 nm and 222 nm, 
indicating the formation of α-helical structure with 
increasing HFIP. Similar HFIP 
concentration-dependent CD spectral changes were 
observed in solutions containing Rep7 or Rep67 (data 
not shown). Consistent with earlier studies, these 
observations indicate that the transition from the 
unfolded state to a partially folded intermediate 
conformation concludes with the formation of α-helix 
rich species as evidenced by the two minima at 208 
nm and 222 nm. 
Closer analysis of the changes in [θ]λ (λ=198 and 
λ=222) of wild type and mutant α-synucleins with 
increasing HFIP concentration indicates that the 
formation of α-helical structure appears to proceed 
through two transitions (Figure 6). To examine the 
transitions in greater detail, we produced phase 
diagrams (Figures 7) showing the relationship 
between [θ]λ198 and [θ]λ222. A linear 
relationship reflects an all-or-none transition between 
two different conformations, while a nonlinear 
relation represents multiple sequential 
transformations. For the wild type α-synuclein, the 
structural changes with increasing HFIP clearly 
proceeds through two transitions (Figure 7): (I) from 
natively unfolded to partially folded (0-3.5% HFIP), 
and (II) from a partially folded intermediate to an 
α-helical conformation (3.5-10% HFIP). These 
observations are also consistent with earlier work [18]. 
Although the Rep6 (Figure 7), Rep7, and Rep67 (data 
not shown) mutants also go through two transitions, 
the break-point HFIP concentration has shifted higher 
than with the wild type protein. Whereas the breaking 
point between the two transitions occurred near 3.5% 
HFIP for wild-type α-synuclein, all three mutants had 
breaking points near 4.5% HFIP (Figure 7). These 
greater HFIP requirements indicate that the reparation 
of the characteristic hexamer motif in the 6th or 7th 
repeat sequence help decrease the propensity of 
α-synuclein to form a partially folded intermediate. 
The first critical step of aggregation and 
fibrillation of α- s y n u c l e i n  i s  c o n s i d e r e d  t o  b e  t h e  Int. J. Biol. Sci. 2007, 3  5
folding from a natively unfolded state to a partially 
folded intermediate [19]. Munishkina et al. [18] 
reported the enhancement of fibril formation by low 
(1-2.5%) concentrations of HFIP in the presence of 
alcohol. Such low concentrations of HFIP were 
sufficient due to the ability of alcohol to stabilize the 
partially folded α-synuclein intermediate. 
Our results clearly indicated that all mutants 
showed the resistant toward formation of partially 
folded structure compared with wild type. Therefore, 
KTKEGV repeats may have significant role in keeping 
native unfolded status of α-synuclein. Since the partial 
folded status is critical step in amyloid fibril forming 
process, the resistance toward the formation of partial 
folded structure revealed that KTKEGV repeats may 
give a positive contribution in preventing fibril 
formation. 
As expected, Rep6 and Rep67 also showed lower 
propensities to aggregate and fibrillate than wild type 
α-synuclein. Although Rep7 also showed difficulty in 
intermediate formation, it appears to have a similar 
propensity to aggregate and fibrillate to wild type 
α-synuclein. Considering that only one amino acid 
was substituted to create Rep7, the NAC region 
remains relatively intact, and the interaction of the 
NAC region may dominate during the fibril or 
aggregation formation. 
Fig. 5. Secondary structures of α-synuclein Rep6 in the presence of various concentrations of HFIP. CD spectra of 
α-synuclein Rep6 were determined in the presence of various concentration of HFIP. 
 
Fig. 6. Comparison of the effects of HFIP on the conformations of α-synuclein WT with Rep6. Dependencies of [θ]MRW 
222 (black circles) and [θ]MRW 198 (white triangles) on HFIP concentration: (a) WT, (b) Rep6. 
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Fig. 7. Phase diagrams for the structural changes induced in α-synuclein WT and Rep6 by HFIP. The effects of HFIP 
on the conformation of α-synucleins: WT (white circles and solid lines), Rep6 (black circles and dashed lines). The roman 
numbers, I and II indicate the phases of transition: (I) from natively unfolded to partially folded intermediate, (II) from 
partially folded intermediate to α-helical conformation. The arrows indicate the breaking points. The break-point HFIP 
concentrations are 3.5% (WT) and 4.5% (Rep6) respectively. 
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